Abstract:Innate immunity is critical for the early detection and elimination of viral invasion. Extracellular signals are crucial for host resistance; however, how extracellular factors prepare the innate immunity for rapid antiviral response remains elusive. Here, we find that serum deprivation largely restricts the innate antiviral responses to RNA and DNA viruses. When serum is supplied, serine/threonine-protein kinase 38-like (STK38L), induced by serum response factor (SRF), phosphorylates IRF3 at Ser303, which prevents IRF3 from proteasome-mediated degradation in the rest state (non-infected), and ensures that enough IRF3 is called in the primed state (infected). STK38L-deficient mice exhibit compromised innate antiviral responses and elevated viral proliferation and mortality. Moreover, lysophosphatidic acid (LPA) or sphingosine 1-phosphate (S1P), the crucial activators of SRF, rescue immunosuppression caused by serum deprivation. These findings identify the SRF-STK38L-IRF3 axis as a novel mechanism that maintains the host in a pro-active state when not infected, which ensures the rapid immune response against virus. Introduction Type I interferon (IFN) is a sophisticated early line of defense used to combat viral infections. Mammalian cells sense viral invasion by germline-encoded pattern-recognition receptors, including Toll-like receptors (TLRs), acid-inducible gene I (RIG-I)-like receptors (RLRs), and several cytosolic DNA sensors. The RNA receptor RIG-I, melanoma differentiation-associated gene 5 (MDA5), and DNA sensors including cyclic GMP-AMP synthase (cGAS) recognize nucleic acids in the cytoplasm and then recruit their adaptor proteins, mitochondrial antiviral signaling protein (MAVS), and stimulator of IFN genes (STING) to initiate a series of signaling cascades that converge at the protein TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε). TBK1 and IKKε phosphorylate and activate transcription factor IFN regulatory factor 3 (IRF3), resulting in the transcription of IFN-β as an initial response and subsequently switching to IRF7-induced IFN-α production. Type I IFNs (IFN-α and IFN-β), sequentially, induce the synthesis of a large number of antiviral IFN-stimulated genes (ISGs) and play a central role in intracellular antiviral defense. 1 Fischer S. Pattern recognition receptors and control of innate immunity: role of nucleic acids. Curr. Pharm. Biotechnol. 2018; 19 : 1203-1209 https://doi.org/10.2174/138920112804583087 Crossref PubMed Scopus (23) Google Scholar , 2 Ma Z. Damania B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe. 2016; 19 : 150-158 https://doi.org/10.1016/j.chom.2016.01.010 Full Text Full Text PDF PubMed Scopus (218) Google Scholar , 3 Marié I. Durbin J.E. Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998; 17 : 6660-6669 https://doi.org/10.1093/emboj/17.22.6660 Crossref PubMed Google Scholar Growing evidence suggests that nutritional status has important implications for host resistance to infection. 4 Wu D. Lewis E.D. Pae M. Meydani S.N. Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front. Immunol. 2018; 9 : 3160 https://doi.org/10.3389/fimmu.2018.03160 < -Abstract Truncated-

XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity

XAF1 Protects Host Against RNA Viruses&nbsp;by Stabilizing IRF1-Dependent Antiviral Immunity

XAF1 promotes anti-RNA virus immune responses by regulating chromatin accessibility

XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

FBXO6 Regulates the Antiviral Immune Responses Via Mediating Alveolar Macrophages Survival

DDX3X Coordinates Host Defense Against Influenza Virus by Activating the NLRP3 Inflammasome and Type I Interferon Response

Mitochondria-localised ZNFX1 functions as a dsRNA sensor to initiate antiviral responses through MAVS

AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation

ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function

IRF1 Promotes the Innate Immune Response to Viral Infection by Enhancing the Activation of IRF3

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner

Axin1: A Novel Scaffold Protein Joins the Antiviral Network of Interferon

Lck/Hck/Fgr-Mediated Tyrosine Phosphorylation Negatively Regulates TBK1 to Restrain Innate Antiviral Responses.

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

LPA maintains innate antiviral immunity in a pro-active state via STK38L-mediated IRF3 Ser303 phosphorylation

The regulatory factor ELF1 triggers a critical wave of transcription in the antiviral response to type I interferon

Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response

RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling

GEF-H1 Controls Microtubule-Dependent Sensing of Nucleic Acids for Antiviral Host Defenses